KURA – kura oncology, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

KURA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/21

09:32 am

kura

Rating for KURA

High Report

Rating for KURA

Report

11/21

09:32 am

kura

Rating for KURA

High Report

Rating for KURA

Report

11/21

09:00 am

kura

Kura Oncology, Inc. (NASDAQ: KURA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Medium Report

Kura Oncology, Inc. (NASDAQ: KURA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Report

11/21

08:44 am

kura

Rating for KURA

High Report

Rating for KURA

Report

11/19

12:46 pm

kura

Kura Oncology, Inc. (NASDAQ: KURA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $32.00 price target on the stock.

Medium Report

Kura Oncology, Inc. (NASDAQ: KURA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $32.00 price target on the stock.

Report

11/19

12:46 pm

kura

Kura Oncology, Inc. (NASDAQ: KURA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $32.00 price target on the stock.

Medium Report

Kura Oncology, Inc. (NASDAQ: KURA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $32.00 price target on the stock.

Report

11/19

12:39 pm

kura

Rating for KURA

Medium Report

Rating for KURA

Report

11/19

12:39 pm

kura

Rating for KURA

Medium Report

Rating for KURA

Report

11/13

08:06 am

kura

Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.

Medium Report

Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.

Report

11/6

10:18 am

kura

Kura Oncology, Inc. (NASDAQ: KURA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Low Report

Kura Oncology, Inc. (NASDAQ: KURA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Report

11/6

09:58 am

kura

Rating for KURA

Low Report

Rating for KURA

Report

11/6

08:06 am

kura

Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.

Low Report

Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.

Report

11/4

06:37 pm

kura

Kura Oncology, Inc. (NASDAQ: KURA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $37.00 price target on the stock.

Low Report

Kura Oncology, Inc. (NASDAQ: KURA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $37.00 price target on the stock.

Report

11/4

06:37 pm

kura

Kura Oncology, Inc. (NASDAQ: KURA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $37.00 price target on the stock.

Low Report

Kura Oncology, Inc. (NASDAQ: KURA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $37.00 price target on the stock.

Report

10/24

08:08 am

kura

Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.

Low Report

Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.

Report

10/24

07:37 am

kura

Rating for KURA

Low Report

Rating for KURA

Report

10/24

07:16 am

kura

Kura Oncology, Inc. (NASDAQ: KURA) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $27.00 price target on the stock.

Medium Report

Kura Oncology, Inc. (NASDAQ: KURA) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $27.00 price target on the stock.

Report

10/14

09:13 am

kura

Rating for KURA

Low Report

Rating for KURA

Report

10/14

07:56 am

kura

Kura Oncology, Inc. (NASDAQ: KURA) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $19.00 price target on the stock, down previously from $26.00.

Low Report

Kura Oncology, Inc. (NASDAQ: KURA) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $19.00 price target on the stock, down previously from $26.00.

Report

10/14

07:56 am

kura

Kura Oncology, Inc. (NASDAQ: KURA) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $19.00 price target on the stock, down previously from $26.00.

Low Report

Kura Oncology, Inc. (NASDAQ: KURA) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $19.00 price target on the stock, down previously from $26.00.

Report

9/9

02:14 pm

kura

Kura Oncology, Inc. (NASDAQ: KURA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Low Report

Kura Oncology, Inc. (NASDAQ: KURA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Report

9/9

01:16 pm

kura

Rating for KURA

Low Report

Rating for KURA

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.